| Date | Title | Description | Source |
| 08.03.2024 | Exagen Inc. to Participate in the KeyBanc Capital Markets Li... | - | globenewsw... |
| 02.01.2024 | Health | A new test could save arthritis patients time, mone... | Arthur Allen | KFF Health News (TNS)
SAN DIEGO — Erinn Maury knew Remicade wasn’t the right drug for... | dailycamer... |
| 13.11.2023 | Exagen Inc. Reports Strong Third Quarter 2023 Results | SAN DIEGO, California, Nov. 13, 2023 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provide... | tullisfund... |
| 07.08.2023 | Exagen Inc. Reports Strong Second Quarter 2023 Results | SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimm... | tullisfund... |
| 24.07.2023 | Exagen Inc. Appoints Paul Kim to Board of Directors | SAN DIEGO, July 24, 2023 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimm... | tullisfund... |
| 15.05.2023 | Exagen Inc. Reports First Quarter 2023 Results | Record Physician Demand for AVISE® CTD | tullisfund... |
| 20.03.2023 | Exagen Inc. Reports Fourth Quarter and Full Year 2022 Result... | Record AVISE® CTD Volume in 2022 | tullisfund... |
| 27.09.2022 | ADM Diagnostics, Inc. Awarded $1.96 Million Grant From the N... | NORTHBROOK, Ill., Sept. 27, 2022 (GLOBE NEWSWIRE) -- ADM Diagnostics, Inc. (ADMdx) has been awarded ... | globenewsw... |
| 26.08.2022 | Octopus rolls out €220 million to drive green power generati... | British renewable energy group specialising in sustainable energy, Octopus Energy Group has unveiled... | tech.eu/20... |
| 04.08.2022 | Exagen Inc. Reports Second Quarter 2022 Results | Records in AVISE® CTD Volume, Ordering Healthcare Providers and Adopters | tullisfund... |
| 09.01.2022 | Exagen Inc. and Queen Mary University of London Announce Exc... | SAN DIEGO, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoim... | marketscre... |
| 10.11.2021 | Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6... | ACTON, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”)... | globenewsw... |
| 10.11.2021 | Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6... | ACTON, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”)... | marketscre... |
| 25.10.2021 | Exagen Inc :. Announces $27.2 Million Debt Refinancing | SAN DIEGO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoim... | marketscre... |
| 15.06.2021 | SQI DIAGNOSTICS INC.
SQI Diagnostics Inc. : Announces $3.9 ... | TORONTO, June 15, 2021 /CNW/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TS... | marketscre... |
| 15.06.2021 | SQI Diagnostics Inc. Announces $3.9 Million Funding via Warr... | | prnewswire... |
| 16.11.2020 | Exagen and GSK Partner for Fourth Straight Year | Continued collaboration drives greater awareness of challenges facing lupus diagnosis and management | tullisfund... |
| 12.10.2020 | New Data Demonstrates Economic Benefit of Exagen’s AVISE® Lu... | Findings support the clinical need for an improved SLE diagnostic test | tullisfund... |
| 29.09.2020 | Exagen Inc. Announces Agreement with Provider Network of Ame... | Expanding Access for AVISE® Tests to 8 Million Members | tullisfund... |
| 23.09.2020 | Exagen Appoints Wendy Johnson to Board of Directors | Additional independent board member will also serve on Audit Committee | tullisfund... |
| 28.07.2020 | Exagen Inc. Reports Second Quarter 2020 Results | Testing experiencing monthly sequential improvement; record gross margins of 63% | tullisfund... |
| 10.12.2019 | National Experts in Autoimmunity Tapped to Serve on Exagen’s... | Members include Dr. Arthur Weinstein, Dr. Joel Kremer, Dr. Anca Askanase, Dr. Andrew Concoff, Dr. Ma... | tullisfund... |
| 22.11.2019 | Exagen Extends Agreement with GSK for a Third Year | Continued collaboration to drive greater awareness about challenges facing lupus diagnosis and manag... | tullisfund... |
| 19.08.2019 | Exagen and the University of Washington Collaborate on Lupus... | Focus on the development of more effective tools to diagnose, prognose and monitor these diseases. | tullisfund... |
| 30.07.2019 | Exagen Inc. Expands Board of Directors with its Appointment ... | Exagen reinforces board with extensive experience across the laboratory testing and healthcare secto... | tullisfund... |
| 02.01.2019 | Exagen Enters Second-Year Agreement with GSK | Collaboration to drive greater awareness about challenges facing lupus diagnosis and management | tullisfund... |
| 11.09.2017 | Exagen Diagnostics Receives Up To $25M in Debt Financing | Exagen Diagnostics Inc., a Vista, CA- and Albuquerque, NM-based commercial stage specialty diagnosti... | finsmes.co... |
| 11.09.2012 |
Exagen Diagnostics Finds $5.3M
| Exagen Diagnostics, a venture-backed developer of molecular diagnostics testing which operates its m... | socaltech.... |
| 11.09.2012 | Exagen Diagnostics Raises $5.3M in Equity Funding | Exagen Diagnostics, a Vista, Calif.-based commercial-stage specialty diagnostic company, has raised ... | finsmes.co... |
